MACROGENICS, INC. Operating Lease, Payments
MACROGENICS, INC. (MGNX) reported Operating Lease, Payments of $5.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-09
- MACROGENICS, INC. operating lease, payments for the quarter ending 2019-12-31 was $1.60M.
- MACROGENICS, INC. operating lease, payments for the quarter ending 2019-09-30 was $1.60M.
- MACROGENICS, INC. operating lease, payments for fiscal 2025 was $5.20M, a 36.84% increase from fiscal 2024.
- MACROGENICS, INC. operating lease, payments for fiscal 2024 was $3.80M, a 35.59% decline from fiscal 2023.
- MACROGENICS, INC. operating lease, payments for fiscal 2023 was $5.90M, a 14.49% decline from fiscal 2022.
- MACROGENICS, INC. operating lease, payments for fiscal 2022 was $6.90M, a 2.99% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.20M 10-K · filed 2026-03-09 | |||
| 2024-12-31 | $3.80M 10-K · filed 2026-03-09 | |||
| 2023-12-31 | $5.90M 10-K · filed 2025-03-20 | |||
| 2022-12-31 | $6.90M 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $6.70M 10-K · filed 2023-03-15 | |||
| 2020-12-31 | $5.90M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.20M derived: sum of 2 quarters · filed 2021-02-25 | $6.40M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $4.80M 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | $3.20M 10-Q · filed 2019-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |